Vimarsana
Biggest News Aggregation in the World

Page 14 - Evaluate Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evaluate Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evaluate Pharma Today - Breaking & Trending Today

Outlook Biotech In 2021 Beyond - Vimarsana News

Outlook Biotech In 2021 Beyond

Biopharma companies have responded in an astounding manner to the COVID-19 pandemic through vaccines, therapies, diagnostics, and variant tracking.

15 years of biosimilar access in Europe - Vimarsana News

15 years of biosimilar access in Europe

Learning from the past to shape the future - Magazine Article - PharmaTimes

Top Pharma Companies by Revenue | Johnson & Johnson is First - Vimarsana News

Top Pharma Companies by Revenue | Johnson & Johnson is First

Here’s a breakdown of the top pharma companies by revenue in 2019, according to information from research firm GlobalData. The pharmaceutical industry is the cornerstone of development, marketing and commercialization for drug treatments and medications for the patient population.  According to data from Statista, revenue in the pharma sector topped US$1 trillion for the first time in 2014, and has steadily increased since then to reach US$1.25 trillion in 2019. North America serves as the largest segment of this growth thanks to the behemoth US pharmaceutical industry. In terms of prescr...

Pharmaceuticals roundup 2020 - Vimarsana News

Pharmaceuticals roundup 2020

Alongside the race for Covid-19 treatments and vaccines, the industry has maintained momentum 2020’s headlines have been dominated by coronavirus since the first reports of a mysterious virus causing pneumonia in Wuhan, China, in January. The pharmaceuticals sector’s response was huge. While the pharma landscape has been somewhat unusual this year, at least some business has carried on. The need for effective and innovative ways to treat disease is something that even a global pandemic will not blunt Of course, a lot of the focus on clinical trials this year has been Covid-19-related, but...